The abstract is read at the publisher; the summary is JClub's.
A handheld fluorescence-spectroscopy plus diffuse reflectance probe in 33 glioma patients discriminated tumor from non-tumor with 85.82% sensitivity and 0.81 AUROC across 212 biopsy-matched sites.
- Why it matters: Visible 5-ALA fluorescence can miss infiltrative glioma because PpIX accumulation is low or heterogeneous, limiting safe maximal resection when tumor does not glow.
- What they did: The probe collected in vivo fluorescence spectroscopy and diffuse reflectance spectroscopy from biopsy-paired, navigation-defined presumed non-tumor sites; a light-transport model corrected fluorescence and quantified biomarkers, then machine learning with patient-grouped leave-one-patient-out cross-validation tested discrimination and histology-defined grading.
- The result: FS+DRS improved tumor detection versus visible fluorescence by +34.3 percentage points sensitivity (p < 0.001) and identified 55/65 nonfluorescent tumor sites, including 19/23 historical LGG sites, while grade discrimination reached 71.98% balanced accuracy (0.71 AUROC).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.